TCEAL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.94400051611865E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.04579999993248E-07 |
Normal-vs-Stage2 |
2.42770000002945E-06 |
Normal-vs-Stage3 |
9.34539999830619E-08 |
Normal-vs-Stage4 |
6.57309762175373E-11 |
Stage1-vs-Stage2 |
1.373580E-01 |
Stage1-vs-Stage3 |
1.110560E-01 |
Stage1-vs-Stage4 |
1.610200E-04 |
Stage2-vs-Stage3 |
8.767200E-01 |
Stage2-vs-Stage4 |
1.669050E-01 |
Stage3-vs-Stage4 |
6.892000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.775799755663E-10 |
Normal-vs-AfricanAmerican |
1.1749999999644E-06 |
Normal-vs-Asian |
1.198240E-02 |
Caucasian-vs-AfricanAmerican |
7.622600E-01 |
Caucasian-vs-Asian |
6.731000E-01 |
AfricanAmerican-vs-Asian |
7.449000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.52230000721931E-09 |
Normal-vs-Female |
1.13739995200035E-09 |
Male-vs-Female |
7.614200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.13910000000417E-05 |
Normal-vs-Age(41-60Yrs) |
5.63530000441403E-08 |
Normal-vs-Age(61-80Yrs) |
1.46610001916514E-09 |
Normal-vs-Age(81-100Yrs) |
1.80804999999618E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.373200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.806000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.506400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.574200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.551980E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.112600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.242390E-02 |
Normal-vs-Grade 2 |
5.92950000000148E-05 |
Normal-vs-Grade 3 |
3.63364893729567E-12 |
Normal-vs-Grade 4 |
1.69779745817777E-11 |
Grade 1-vs-Grade 2 |
6.655400E-01 |
Grade 1-vs-Grade 3 |
1.335850E-02 |
Grade 1-vs-Grade 4 |
4.765400E-04 |
Grade 2-vs-Grade 3 |
1.177400E-04 |
Grade 2-vs-Grade 4 |
1.18689999994981E-06 |
Grade 3-vs-Grade 4 |
2.028500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.41840000000582E-05 |
Normal-vs-ccB subtype |
2.45619968808342E-10 |
ccA subtype-vs-ccB subtype |
1.448570E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.49139997521297E-09 |
Normal-vs-N1 |
6.68730000041862E-07 |
N0-vs-N1 |
2.937700E-02 |
|
|